CD14 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,147 results for “CD14”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

COVID-19 and Anti-CD14 Treatment Trial

49 participants · First posted May 18, 2020

Serum CD14 and CD88 Mointoring in ICU

80 participants · First posted Apr 22, 2014

Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients

56 participants · First posted Jul 22, 2024

Not yet recruiting

Pilot and Feasibility Study of Anti-CD14 for the Treatment of Knee Osteoarthritis

40 participants · First posted Mar 18, 2026

Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI

10 participants · First posted Nov 7, 2024

No Longer Available

Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19)

First posted Apr 15, 2020

Circulating Endothelial Progenitor Cells and Aortic Aneurysm

40 participants · First posted Aug 8, 2013

Reference Values of Circulating Endothelial Progenitor Cells

120 participants · First posted Aug 8, 2013

Changes in Inflammatory Biomarkers Including Soluble CD14 and Hyperreflective Foci in DME Patients Treated With Aflibercept (FORESIGHT)

23 participants · First posted Dec 19, 2018

Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis Patients

200 participants · First posted Jan 8, 2019

Page 1 of 135